United States (US) GLP 1 Receptor Agonist Market (2025-2031) | Trends, Industry, Share, Competitive Landscape, Forecast, Companies, Value, Analysis, Outlook, Segmentation, Size & Revenue, Growth

Name: United States (US) GLP 1 Receptor Agonist Market (2025-2031) | Trends & Industry
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Product (Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda), By Application (Type 2 Diabetes Mellitus, Obesity), By Route of Administration (Parenteral, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape

Product Code: ETC9966625	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) GLP 1 Receptor Agonist Market Outlook
Market Size of United States (US) GLP 1 Receptor Agonist Market, 2024
Forecast of United States (US) GLP 1 Receptor Agonist Market, 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Revenues & Volume for the Period 2021- 2031
United States (US) GLP 1 Receptor Agonist Market Trend Evolution
United States (US) GLP 1 Receptor Agonist Market Drivers and Challenges
United States (US) GLP 1 Receptor Agonist Price Trends
United States (US) GLP 1 Receptor Agonist Porter's Five Forces
United States (US) GLP 1 Receptor Agonist Industry Life Cycle
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Ozempic for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Trulicity for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Mounjaro for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Wegovy for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Rybelsus for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Saxenda for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Type 2 Diabetes Mellitus for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Obesity for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Parenteral for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
United States (US) GLP 1 Receptor Agonist Import Export Trade Statistics
Market Opportunity Assessment By Product
Market Opportunity Assessment By Application
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Distribution Channel
United States (US) GLP 1 Receptor Agonist Top Companies Market Share
United States (US) GLP 1 Receptor Agonist Competitive Benchmarking By Technical and Operational Parameters
United States (US) GLP 1 Receptor Agonist Company Profiles
United States (US) GLP 1 Receptor Agonist Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) GLP 1 Receptor Agonist Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) GLP 1 Receptor Agonist Market - Industry Life Cycle

3.4 United States (US) GLP 1 Receptor Agonist Market - Porter's Five Forces

3.5 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) GLP 1 Receptor Agonist Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the United States.

4.2.2 Growing awareness about the benefits of GLP-1 receptor agonists in managing diabetes.

4.2.3 Rising adoption of novel therapies by healthcare professionals in the US.

4.3 Market Restraints

4.3.1 High cost associated with GLP-1 receptor agonist medications.

4.3.2 Competition from other classes of diabetes medications.

4.3.3 Stringent regulatory requirements for approval and marketing of GLP-1 receptor agonists.

5 United States (US) GLP 1 Receptor Agonist Market Trends

6 United States (US) GLP 1 Receptor Agonist Market, By Types

6.1 United States (US) GLP 1 Receptor Agonist Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Ozempic, 2021- 2031F

6.1.4 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Trulicity, 2021- 2031F

6.1.5 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Mounjaro, 2021- 2031F

6.1.6 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Wegovy, 2021- 2031F

6.1.7 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Rybelsus, 2021- 2031F

6.1.8 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Saxenda, 2021- 2031F

6.2 United States (US) GLP 1 Receptor Agonist Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Type 2 Diabetes Mellitus, 2021- 2031F

6.2.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Obesity, 2021- 2031F

6.3 United States (US) GLP 1 Receptor Agonist Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F

6.4 United States (US) GLP 1 Receptor Agonist Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.4 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7 United States (US) GLP 1 Receptor Agonist Market Import-Export Trade Statistics

7.1 United States (US) GLP 1 Receptor Agonist Market Export to Major Countries

7.2 United States (US) GLP 1 Receptor Agonist Market Imports from Major Countries

8 United States (US) GLP 1 Receptor Agonist Market Key Performance Indicators

8.1 Patient adherence rate to GLP-1 receptor agonist therapy.

8.2 Number of clinical trials investigating new applications of GLP-1 receptor agonists.

8.3 Prescription rates of GLP-1 receptor agonists by healthcare providers.

8.4 Percentage of diabetic patients switching to GLP-1 receptor agonists as a first-line therapy option.

9 United States (US) GLP 1 Receptor Agonist Market - Opportunity Assessment

9.1 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) GLP 1 Receptor Agonist Market - Competitive Landscape

10.1 United States (US) GLP 1 Receptor Agonist Market Revenue Share, By Companies, 2024

10.2 United States (US) GLP 1 Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa GLP 1 Receptor Agonist Market

Equatorial Guinea GLP 1 Receptor Agonist Market

Eritrea GLP 1 Receptor Agonist Market

Estonia GLP 1 Receptor Agonist Market

Ethiopia GLP 1 Receptor Agonist Market

Fiji GLP 1 Receptor Agonist Market

Global GLP 1 Receptor Agonist Market

Middle East GLP 1 Receptor Agonist Market

North America GLP 1 Receptor Agonist Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here